Researchers identify APOC1 and NOP16 as promising prostate cancer biomarkers that could aid early diagnosis. Learn more about ...

Mar. 23 -- FRIDAY, June 1 (HealthDay News) -- A protein that is used as a marker of heart disease may also predict survival odds and response to chemotherapy for men with advanced prostate cancer.

A study on non-coding RNA (Ribonucleic Acid) from prostate cancer patients has identified a series of new prostate cancer markers which can be found in urine. Combining these RNA markers into a single ...

Scientists have taken a first step toward improving those problematic PSA tests for prostate cancer, by mixing in some genetic information that might help tell which men really need a biopsy. The ...

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer Research UK. Cancer Research UK-funded scientists, ...

ORLANDO, Fla. (Ivanhoe Newswire) --- Prostate cancer is the second leading cause of death in men right behind heart disease. Patients with this cancer often don’t find out until the disease has ...

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer Research UK. Cancer Research UK-funded scientists, ...

Targeted cancer therapies are an expanding field of effective therapeutic approaches. While previous chemotherapy agents indiscriminately killed rapidly proliferating cells, newer “precision medicine” ...

Monte Rosa Therapeutics surged Tuesday after the biotech said every patients in a prostate cancer study responded to its ...